Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+). (Q40080790)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 August 2017

Language	Label	Description	Also known as
English	Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).	scientific article published on 24 August 2017

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

António Almeida

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Raphael A Itzykson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

20

object named as

Pierre Fenaux

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Valerie Seegers

14

object named as

Valerie Seegers

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

3

object named as

Sylvain Thépot

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

5

object named as

Luca Maurillo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sonja Burgstaller

12

object named as

Sonja Burgstaller

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Reinhard Stauder

7

object named as

Reinhard Stauder

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

11

object named as

Joan Bargay

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

18

object named as

Pau Montesinos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

2

object named as

Lisa Pleyer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

21

object named as

Richard Greil

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

José F Falantes

1

object named as

José Falantes

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Violeta Martínez-Robles

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Ricardo Pinto

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Adriano Venditti

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

María Pilar Martínez

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Emilia Cortesão

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

María Ángeles Foncillas

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Claude Gardin

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Pellegrino Musto

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Fernando Ramos

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

European ALMA + Investigators

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

publication date

24 August 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

59

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1113-1120

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Age and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Survival for older patients with acute myeloid leukemia: a population-based study

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Intensive chemotherapy, azacitidine, or supportive care in older acute myeloid leukemia patients: an analysis from a regional healthcare network

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Geriatric oncology and clinical trials

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1080%2F10428194.2017.1365854

21 January 2018

Identifiers

10.1080/10428194.2017.1365854

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28838276%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40080790&oldid=1835259667"